This becomes especially critical in conditions where systemic inflammation, with an expected decreased PON-1 activity (e.g., canine leishmaniasis, leptospirosis), may coexist with hepatic disease, possibly causing an increase (liver injury) or a further decrease (liver failure) in PON-1 activity. This evidence concerns the gene PON1 and liver disorder.